Logo image of KNSA

KINIKSA PHARMACEUTICALS INTE (KNSA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:KNSA - GB00BRXB0C07 - Common Stock

41.03 USD
-1.49 (-3.5%)
Last: 12/1/2025, 1:59:20 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
KNSA revenue by date.KNSA revenue by date.
220.18M
471.24%
270.259M
22.74%
423.239M
56.60%
688.32M
62.63%
879.72M
27.81%
1.029B
16.97%
1.19B
15.65%
1.29B
8.40%
1.392B
7.91%
1.691B
21.48%
1.806B
6.80%
EBITDA
YoY % growth
KNSA ebitda by date.KNSA ebitda by date.
12.173M
107.89%
-22.855M
-287.75%
-43.921M
-92.17%
112.87M
356.98%
189.63M
68.01%
276.16M
45.63%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
KNSA ebit by date.KNSA ebit by date.
9.773M
106.24%
-25.196M
-357.81%
-45.616M
-81.04%
97.749M
314.29%
138.98M
42.18%
217.38M
56.41%
214.26M
-1.44%
309.57M
44.48%
446.11M
44.11%
767.04M
71.94%
856.29M
11.64%
Operating Margin
KNSA operating margin by date.KNSA operating margin by date.
4.44%-9.32%-10.78%14.20%15.80%21.13%18.01%24.00%32.05%45.36%47.41%
EPS
YoY % growth
KNSA eps by date.KNSA eps by date.
2.59
212.61%
0.18
-93.05%
-0.61
-438.89%
1.06
273.50%
1.73
63.13%
2.62
51.90%
2.96
12.80%
2.963.45
16.55%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.42
447.17%
0.34
208.32%
0.41
79.61%
0.45
96.24%
0.56
34.66%
Revenue
Q2Q % growth
196.37M
60.25%
214.26M
55.50%
226.87M
44.69%
239.04M
32.17%
234.29M
19.31%
EBITDA
Q2Q % growth
38.196M
316.97%
26.026M
91.13%
36.02M
72.65%
42.556M
69.49%
N/A
EBIT
Q2Q % growth
33.702M
274.63%
33.82M
154.82%
40.66M
101.69%
45.769M
90.54%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.23
227.78%
0.33-0.10-30.25%
Q2 2025
Q2Q % growth
0.23
483.33%
0.190.0423.78%
Q1 2025
Q2Q % growth
0.11
144.00%
0.040.07156.77%
Q4 2024
Q2Q % growth
-0.12
-134.29%
0.00-0.12-5,782.35%
Q3 2024
Q2Q % growth
-0.18
10.00%
0.03-0.21-651.47%
Q2 2024
Q2Q % growth
-0.06
-128.57%
-0.080.0221.57%
Q1 2024
Q2Q % growth
-0.25
-38.89%
-0.17-0.08-50.06%
Q4 2023
Q2Q % growth
0.35
483.33%
-0.140.49345.10%
Q3 2023
Q2Q % growth
-0.20
-106.29%
-0.17-0.03-17.06%
Q2 2023
Q2Q % growth
0.21
172.41%
-0.170.38222.91%
Q1 2023
Q2Q % growth
-0.18
50.00%
-0.210.0314.95%
Q4 2022
Q2Q % growth
0.06
111.32%
-0.240.30125.30%
Q3 2022
Q2Q % growth
3.18
822.73%
0.802.38298.42%
Q2 2022
Q2Q % growth
-0.29
52.46%
-0.450.1635.75%
Q1 2022
Q2Q % growth
-0.36
50.00%
-0.410.0513.21%
Q4 2021
Q2Q % growth
-0.53
32.91%
-0.43-0.10-23.72%
Q3 2021
Q2Q % growth
-0.44
33.33%
-0.660.2233.38%
Q2 2021
Q2Q % growth
-0.61
6.15%
-0.810.2024.54%
Q1 2021
Q2Q % growth
-0.72
-50.00%
-0.740.022.64%
Q4 2020
Q2Q % growth
-0.79
-36.21%
-0.63-0.16-24.42%
Q3 2020
Q2Q % growth
-0.66
-34.69%
-0.62-0.04-6.95%
Q2 2020
Q2Q % growth
-0.65
4.41%
-0.64-0.01-1.80%
Q1 2020
Q2Q % growth
-0.48
62.20%
-0.650.1725.77%
Q4 2019
Q2Q % growth
-0.58 -0.630.058.29%
Q3 2019
Q2Q % growth
-0.49 -0.730.2433.05%
Q2 2019
Q2Q % growth
-0.68 -0.730.057.08%
Q1 2019
Q2Q % growth
-1.27 -0.82-0.45-55.64%
KNSA Yearly EPS VS EstimatesKNSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
180.855M
61.17%
170.71M10.145M5.94%
Q2 2025
Q2Q % growth
156.797M
51.65%
149.35M7.447M4.99%
Q1 2025
Q2Q % growth
137.785M
72.54%
133.07M4.715M3.54%
Q4 2024
Q2Q % growth
122.536M
46.93%
125.84M-3.304M-2.63%
Q3 2024
Q2Q % growth
112.214M
67.37%
113.75M-1.536M-1.35%
Q2 2024
Q2Q % growth
103.391M
44.66%
94.159M9.232M9.80%
Q1 2024
Q2Q % growth
79.858M
65.18%
80.029M-171K-0.21%
Q4 2023
Q2Q % growth
83.395M
34.76%
73.459M9.936M13.53%
Q3 2023
Q2Q % growth
67.046M
-32.37%
65.736M1.31M1.99%
Q2 2023
Q2Q % growth
71.473M
164.99%
53.24M18.233M34.25%
Q1 2023
Q2Q % growth
48.345M
50.19%
47.508M837K1.76%
Q4 2022
Q2Q % growth
61.884M
230.14%
46.018M15.866M34.48%
Q3 2022
Q2Q % growth
99.135M
719.64%
95.516M3.619M3.79%
Q2 2022
Q2Q % growth
26.972M
250.10%
29.124M-2.152M-7.39%
Q1 2022
Q2Q % growth
32.189M 23.226M8.963M38.59%
Q4 2021
Q2Q % growth
18.745M 21.139M-2.394M-11.33%
Q3 2021
Q2Q % growth
12.095M 10.38M1.715M16.52%
Q2 2021
Q2Q % growth
7.704M 4.048M3.656M90.32%
Q1 2021
Q2Q % growth
7.931M-7.931M-100.00%
KNSA Yearly Revenue VS EstimatesKNSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS8.34% 124.41% -2.81% 144.71%
Revenue8.01% 21.55% 5.65% 18.53%